Company
RESTERA
Restera is a clinical-stage medical technology company developing a first-of-its-kind treatment for sleep apnea.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Restera has united a world-class team of clinicians, engineers, investors, and leading research institutions with a shared mission: to deliver a transformative treatment for Obstructive Sleep Apnea (OSA).
Funding snapshot
- Total raised
- $25MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $25M2023
Funding rounds
- Series A
- $25M2023, Company stated
Products
- Hardware
- Restera System
Loading relationship preview